Glucose monitoring in youth with cystic fibrosis
Part of Hormones & metabolism, Lungs & breathing clinical trials.
This study uses a continuous glucose monitor (a small sensor on the arm) to track blood sugar levels in young people with cystic fibrosis during a lung infection flare-up (called a pulmonary exacerbation). It aims to see if glucose changes can help guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 25 years old.
- You have a confirmed diagnosis of cystic fibrosis (by sweat test or genetic test).
- You have a smartphone or internet and can do remote telehealth visits.
- You do not have type 1 or type 2 diabetes or other genetic forms of diabetes.
- You are not critically ill (requiring ICU care).
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand what causes and increases the risk of lung infections (exacerbations) in people with cystic fibrosis. It involves regular monitoring and sample collection at home and in the clinic to identify early warning signs.
This study uses continuous glucose monitoring (a sensor that checks blood sugar trends) to understand how sugar handling changes over time in people with cystic fibrosis. It may help doctors spot early “pre-diabetes” or abnormal sugar patterns sooner.
This study tests if a continuous glucose monitor (CGM) along with a standard glucose drink test can better detect diabetes in people with cystic fibrosis. It is for adults who do not yet have diabetes and are generally healthy.
This study uses a continuous glucose monitor (CGM), a small sensor worn on the skin, to track blood sugar levels in people with cystic fibrosis (CF) who do not have diabetes or have prediabetes. The goal is to find patterns that might predict who will develop diabetes, so it can be caught earlier.
This study tests whether a small continuous glucose monitor (a sensor that checks your sugar levels all the time) can be used easily in youth who are in the hospital. It may help doctors track your blood sugar closely without needing as many finger sticks.
This study looks at how the body handles sugar in people with cystic fibrosis related diabetes. Researchers want to learn more about glucose metabolism to improve care for people with CFRD.
Hear when a new Cystic Fibrosis Pulmonary Exacerbation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.